EzriCare & Delsam Pharma Eye Drops Lawsuit

Eye Drops

A series of lawsuits have recently been initiated against EzriCare and Delsam Pharma, two pharmaceutical companies whose artificial tear eye drops have been linked to a multi-state bacterial outbreak. The legal battle against these two companies is intensifying as more lawsuits are filed after the recall, drawing substantial attention from various sectors.

At Jeffrey Glassman Injury Lawyers, our team of experienced attorneys is committed to advocating for clients in product liability lawsuits. We specialize in cases arising from injuries caused by defective products, such as the EzriCare & Delsam Pharma Eye Drops.

The Intricacies of the Lawsuit

The lawsuit against EzriCare and Delsam Pharma is complex, with numerous charges being leveled against both companies. The charges provide insight into the intricacy of the case, revealing the depth of the situation. The bacterial outbreak, its origins, the alarming rate of its spread, and the effectiveness of the control measures are under scrutiny. The outbreak is believed to have been caused by a specific strain of bacteria potentially disseminated through the eye drops.

The Human Cost of the Outbreak

The toll the outbreak has taken on its victims is both physical and emotional. The symptoms endured by the victims, the treatments administered, and the ongoing challenges faced by them paint a grim picture. The emotional and psychological impact of the outbreak on the victims and their families adds a deeper layer to the unfolding drama of the EzriCare & Delsam Pharma Eye Drops Lawsuit.

The Outbreak and Its Effects

The Centers for Disease Control and Prevention (CDC) is currently investigating an outbreak of infections caused by a rare, drug-resistant strain of bacteria, Carbapenem-resistant Pseudomonas aeruginosa (CRPA), linked to the use of EzriCare and Delsam Pharma’s eye drops. 

The fallout from the outbreak has been severe. As of May 15, 2023, the CDC reported that 81 individuals across 18 states have been infected. Tragically, 14 of these individuals have suffered vision loss, four have had to undergo surgery to remove their eyeballs, and four others have died as a result of the infections.

The Legal Response

In the wake of the outbreak, EzriCare and Delsam Pharma face numerous lawsuits. These lawsuits, still in their early stages, include both individual injury lawsuits and class-action lawsuits. Individual lawsuits seek compensation for the infections and eye problems caused by the contaminated eye drops. Teresa Phillips, a Florida resident forced to undergo eye surgery due to complications from an eye infection, was one of the first to file such a lawsuit. On the other hand, class-action lawsuits represent multiple injured people and demand refunds for the purchase price of the eye drops plus compensation for how it has affected their lives. 

Richard Mosley, a Kentucky resident, filed a class action complaint (CAC) claiming that the products were contaminated due to violations of the U.S. Food and Drug Administration’s Current Good Manufacturing Practice regulations. Amazon and Walmart, where the eye drops were sold, have also been named in the lawsuits. Legal experts expect that the volume of lawsuits may lead to consolidation into multidistrict litigation (MDL).


The Recall

In February 2023, at the FDA’s request, Global Pharma issued a recall for all unexpired lots of EzriCare and Delsam Pharma’s artificial tears and Delsam Pharma’s Artificial Eye Ointment. The FDA also issued a Safety Communication warning consumers to stop using these products.

Looking Forward

People who have suffered eye infections, vision loss, or other injuries after using these artificial tears products may qualify for a lawsuit. Anyone experiencing symptoms of an eye infection, such as itchy or painful eyes, is advised to see a doctor as soon as possible, as late treatment could increase the risk of infection-related complications. 

In Massachusetts, like all states, there are specific time limits for initiating a lawsuit. If you’re uncertain about your eligibility, it’s crucial to reach out to a knowledgeable attorney as soon as possible to explore your potential legal options.

The Broader Implications

This case underscores the broader implications of product safety, consumer trust, and corporate responsibility. The EzriCare & Delsam Pharma Eye Drops Lawsuit is more than just a legal battle between consumers and pharmaceutical companies. It’s a stark reminder of the potential consequences of negligence in the production and distribution of health-related products. The toll of this outbreak on individuals and communities sheds light on the importance of maintaining high standards in manufacturing and quality control.

The Role of Regulatory Bodies

The role of regulatory bodies like the FDA in ensuring product safety also comes into focus in light of this case. With the recall of eye drops, the FDA’s role in protecting consumers has been highlighted. The agency’s ongoing involvement in the investigation and its potential role in future settlements or trials will be areas to watch as the case unfolds.

The Path Ahead

As we look ahead, it’s clear that this case will continue to evolve and likely set precedents for product liability and consumer protection. It will be a strong part of shaping laws and regulations related to product safety and could potentially influence future manufacturing practices in the pharmaceutical industry.

Product Safety


As this case continues to unfold, it is essential to stay informed about this significant legal battle. This EzriCare & Delsam Pharma Eye Drops Lawsuit is not just a matter of corporate responsibility, but it also highlights the importance of consumers’ rights and the need for transparency from corporations about their products. 

Remember, consumer safety is paramount, and it’s crucial to stay informed about the products we use daily. This case serves as a stark reminder of the importance of vigilance in ensuring the safety and efficacy of products, particularly those that have a direct impact on your health.

Contact Jeffrey Glassman Injury Lawyers

If you or someone close to you has been affected by this bacterial outbreak, please know you’re not alone. Our team at Jeffrey Glassman Injury Lawyers is committed to standing up for the rights of victims and ensuring they get the compensation they’re rightfully owed. Time is of the essence in these cases, so don’t delay. Reach out to us at (617) 777-7777 or submit our online form to begin the process. Allow us to navigate you on your journey toward rightful compensation.

Contact Information